Uncategorized

Novo Nordisk’s diabetes pill slashes risk of cardiovascular complications by 14% after four years – CNBC

Posted on Author Tim Hodges Comments Off on Novo Nordisk’s diabetes pill slashes risk of cardiovascular complications by 14% after four years – CNBC
  1. Novo Nordisk’s diabetes pill slashes risk of cardiovascular complications by 14% after four years  CNBC
  2. Semaglutide, or Ozempic, reduces symptoms of feared diabetes’ complication, study finds  The Globe and Mail
  3. Lancet study shows Ozempic can help people with diabetes walk better despite poor blood flow to limbs  The Indian Express
  4. STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients  TCTMD
  5. Increasing walking capacity in patients with peripheral artery disease  The Lancet